The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Research progress in miRNA biomarkers of prostate cancer and radiosensitivity
Pages: 227-232
Year: Issue:  3
Journal: International Journal of Radiation Medicine and Nuclear Medicine

Abstract: Prostate cancer is the most common malignant tumor in the male urinary system.miRNA is a newly discovered small non-coding RNA of 19-23bp nucleotides,which was involved in regulating many important biological functions,even play a key role in tumor development.The blood research has indicated miRNA in blood could be a biomarker for diagnosis of prostate cancer but did not find specific extracellular miRNA as a prostate cancer biomarkers.Investigate the expression and the action mechanism of miRNA of prostate cancer have a great meaning to further discuss the pathogenesis of prostate cancer,search for new diagnostic and therapeutic method.This review focuses on the different abundance of miRNA among healthy population,patients with prostate cancer,patients with metastatic prostate cancer and moderating effect of miRNA of prostate cancer on tumor radiosensitivity,try to explore the clues of miRNA as biological markers for prostate cancer.
Related Articles
No related articles found